1.43

8.33% +0.11

After Hours: 1.42 -0.01 -0.70%

NKGen Biotech Inc (NKGN)

Overview News Price History Why NKGN Down? Discussions Forecast

NKGen Biotech Inc stock is currently priced at $1.43, with a 24-hour trading volume of 209.36K. It has seen a +8.33% increased in the last 24 hours and a -7.74% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $1.38 pivot point. If it approaches the $1.49 resistance level, significant changes may occur.

Previous Close:

$1.32

Open:

$1.33

24h Volume:

209.36K

Market Cap:

$32.17M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

-11.18%

1M Performance:

-7.74%

6M Performance:

-53.11%

1Y Performance:

+0.00%

1D Range:

$1.32

$1.55

52W Range:

$0.7802

$6.70

NKGen Biotech Inc Stock (NKGN) Company Profile

Name

NKGen Biotech Inc

Sector

Healthcare (1213)

Industry

Biotechnology (699)

Phone

346-442-0819

Address

1790 Hughes Landing Boulevard, Suite 400, The Woodlands

Employee

Twitter

Next Earnings Date

Latest SEC Filings

NKGN's Discussions on Twitter

NKGen Biotech Inc Stock (NKGN) Latest News

NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit

GlobeNewswire Inc.

NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire Inc.

NKGen Biotech Announces Upcoming Presentation on SNK01 NK Cell Therapy in Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit

GlobeNewswire Inc.

NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs

GlobeNewswire Inc.

NKGen Biotech Presents Additional Phase 1 Clinical Trial Data in Alzheimer’s Disease at the Tau2024 Global Conference

GlobeNewswire Inc.

Trading Penny Stocks With $1,000, Top Tips

PennyStocks

NKGen Biotech Inc Stock (NKGN) Financials Data

There is no financial data for NKGen Biotech Inc (NKGN). Check out other stocks for more information.

NKGen Biotech Inc Stock (NKGN) Insider Trading

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total
Song Paul Y.	Chief Executive Officer	Dec 06 '23	Buy	3.32	75	250	171,045
Song Paul Y.	Chief Executive Officer	Dec 05 '23	Buy	3.33	105	350	170,969
Graf James A	Interim CFO	Dec 04 '23	Buy	3.19	450	1,436	693
Song Paul Y.	Chief Executive Officer	Dec 04 '23	Buy	3.07	163	500	170,864
Graf James A	Interim CFO	Dec 01 '23	Buy	3.35	220	737	243
Song Paul Y.	Chief Executive Officer	Nov 27 '23	Buy	2.88	244	701	170,701
Song Paul Y.	Chief Executive Officer	Nov 22 '23	Buy	2.85	53	150	170,458
Song Paul Y.	Chief Executive Officer	Nov 21 '23	Buy	2.80	100	280	170,405
Graf James A	Interim CFO	Nov 21 '23	Buy	2.92	13	38	23
Graf James A	Interim CFO	Nov 20 '23	Buy	2.94	10	29	10

Graf Acquisition Corp. IV does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. Graf Acquisition Corp. IV was incorporated in 2021 and is based in The Woodlands, Texas.